Aristides Capital LLC Celldex Therapeutics, Inc. Transaction History
Aristides Capital LLC
- $260 Million
- Q4 2024
A detailed history of Aristides Capital LLC transactions in Celldex Therapeutics, Inc. stock. As of the latest transaction made, Aristides Capital LLC holds 8,000 shares of CLDX stock, worth $166,240. This represents 0.08% of its overall portfolio holdings.
Number of Shares
8,000Holding current value
$166,240% of portfolio
0.08%Shares
1 transactions
Others Institutions Holding CLDX
# of Institutions
196Shares Held
60.7MCall Options Held
960KPut Options Held
675K-
Kynam Capital Management, LP Princeton, NJ5.06MShares$105 Million8.11% of portfolio
-
Black Rock Inc. New York, NY4.69MShares$97.5 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.88MShares$80.7 Million0.0% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.75MShares$78 Million1.82% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.56MShares$73.9 Million0.01% of portfolio
About Celldex Therapeutics, Inc.
- Ticker CLDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 46,772,400
- Market Cap $972M
- Description
- Celldex Therapeutics, Inc., a biopharmaceutical company, engages in developing therapeutic monoclonal and bispecific antibodies for the treatment of various diseases. Its drug candidates include antibody-based therapeutics to treat patients with inflammatory diseases and various forms of cancer. The company's clinical development programs CDX-01...